216 related articles for article (PubMed ID: 29845256)
1. Cold PSM, but not TRAIL, triggers autophagic cell death: A therapeutic advantage of PSM over TRAIL.
Ito T; Ando T; Suzuki-Karasaki M; Tokunaga T; Yoshida Y; Ochiai T; Tokuhashi Y; Suzuki-Karasaki Y
Int J Oncol; 2018 Aug; 53(2):503-514. PubMed ID: 29845256
[TBL] [Abstract][Full Text] [Related]
2. Autophagy inhibitors regulate TRAIL sensitivity in human malignant cells by targeting the mitochondrial network and calcium dynamics.
Onoe-Takahashi A; Suzuki-Karasaki M; Suzuki-Karasaki M; Ochiai T; Suzuki-Karasaki Y
Int J Oncol; 2019 May; 54(5):1734-1746. PubMed ID: 30896851
[TBL] [Abstract][Full Text] [Related]
3. Plasma-stimulated medium kills TRAIL-resistant human malignant cells by promoting caspase-independent cell death via membrane potential and calcium dynamics modulation.
Tokunaga T; Ando T; Suzuki-Karasaki M; Ito T; Onoe-Takahashi A; Ochiai T; Soma M; Suzuki-Karasaki Y
Int J Oncol; 2018 Mar; 52(3):697-708. PubMed ID: 29393427
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Ca2+ removal amplifies TRAIL cytotoxicity toward apoptosis-resistant tumor cells via promotion of multiple cell death modalities.
Takata N; Ohshima Y; Suzuki-Karasaki M; Yoshida Y; Tokuhashi Y; Suzuki-Karasaki Y
Int J Oncol; 2017 Jul; 51(1):193-203. PubMed ID: 28560396
[TBL] [Abstract][Full Text] [Related]
5. Disrupting mitochondrial Ca2+ homeostasis causes tumor-selective TRAIL sensitization through mitochondrial network abnormalities.
Ohshima Y; Takata N; Suzuki-Karasaki M; Yoshida Y; Tokuhashi Y; Suzuki-Karasaki Y
Int J Oncol; 2017 Oct; 51(4):1146-1158. PubMed ID: 28849210
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effects of delphinidin in human osteosarcoma cells.
Lee DY; Park YJ; Hwang SC; Kim KD; Moon DK; Kim DH
Acta Orthop Traumatol Turc; 2018 Jan; 52(1):58-64. PubMed ID: 29290536
[TBL] [Abstract][Full Text] [Related]
7. Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells.
Hori T; Kondo T; Kanamori M; Tabuchi Y; Ogawa R; Zhao QL; Ahmed K; Yasuda T; Seki S; Suzuki K; Kimura T
J Orthop Res; 2010 Jun; 28(6):739-45. PubMed ID: 20041491
[TBL] [Abstract][Full Text] [Related]
8. Cytoprotective role of autophagy during paclitaxel-induced apoptosis in Saos-2 osteosarcoma cells.
Kim HJ; Lee SG; Kim YJ; Park JE; Lee KY; Yoo YH; Kim JM
Int J Oncol; 2013 Jun; 42(6):1985-92. PubMed ID: 23563171
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM
Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538
[TBL] [Abstract][Full Text] [Related]
10. Genistein enhances TRAIL-induced cancer cell death via inactivation of autophagic flux.
Nazim UM; Park SY
Oncol Rep; 2015 Nov; 34(5):2692-8. PubMed ID: 26352862
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of oxidative stress, apoptosis, and autophagy involved in graphene oxide nanomaterial anti-osteosarcoma effect.
Tang Z; Zhao L; Yang Z; Liu Z; Gu J; Bai B; Liu J; Xu J; Yang H
Int J Nanomedicine; 2018; 13():2907-2919. PubMed ID: 29844673
[TBL] [Abstract][Full Text] [Related]
12. The induction of autophagy against mitochondria-mediated apoptosis in lung cancer cells by a ruthenium (II) imidazole complex.
Chen L; Li G; Peng F; Jie X; Dongye G; Cai K; Feng R; Li B; Zeng Q; Lun K; Chen J; Xu B
Oncotarget; 2016 Dec; 7(49):80716-80734. PubMed ID: 27811372
[TBL] [Abstract][Full Text] [Related]
13. TRAIL enhances quinacrine-mediated apoptosis in breast cancer cells through induction of autophagy via modulation of p21 and DR5 interactions.
Das S; Nayak A; Siddharth S; Nayak D; Narayan S; Kundu CN
Cell Oncol (Dordr); 2017 Dec; 40(6):593-607. PubMed ID: 28936683
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells.
Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
Biochem Biophys Res Commun; 2013 Sep; 439(2):179-86. PubMed ID: 23994633
[TBL] [Abstract][Full Text] [Related]
15. Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo.
Zhu J; Yu W; Liu B; Wang Y; Shao J; Wang J; Xia K; Liang C; Fang W; Zhou C; Tao H
Cell Death Dis; 2017 Oct; 8(10):e3113. PubMed ID: 29022891
[TBL] [Abstract][Full Text] [Related]
16. Distinct effects of TRAIL on the mitochondrial network in human cancer cells and normal cells: role of plasma membrane depolarization.
Suzuki-Karasaki Y; Fujiwara K; Saito K; Suzuki-Karasaki M; Ochiai T; Soma M
Oncotarget; 2015 Aug; 6(25):21572-88. PubMed ID: 26057632
[TBL] [Abstract][Full Text] [Related]
17. Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.
Ma K; Zhang C; Huang MY; Li WY; Hu GQ
Oncol Rep; 2016 Jul; 36(1):90-8. PubMed ID: 27176794
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between Beclin-1-dependent autophagy and caspase‑dependent apoptosis induced by tanshinone IIA in human osteosarcoma MG-63 cells.
Ma K; Zhang C; Huang MY; Guo YX; Hu GQ
Oncol Rep; 2016 Oct; 36(4):1807-18. PubMed ID: 27499329
[TBL] [Abstract][Full Text] [Related]
19. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
Jayasooriya RG; Choi YH; Hyun JW; Kim GY
Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556
[TBL] [Abstract][Full Text] [Related]
20. Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co-operatively induce apoptotic cell death in both sarcoma and myeloma cells.
Suzuki H; Hotta T; Koyama T; Komagata M; Imakiire A; Yanase N; Yoshimoto T; Mizuguchi J
Anticancer Res; 2003; 23(4):3247-53. PubMed ID: 12926060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
